Knowles Lindsey M, Phillips Kala M, Herring Tracy E, Alschuler Kevin N, Jensen Mark P, Turner Aaron P, Ehde Dawn M
Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA; Multiple Sclerosis Center of Excellence-West, Veterans Administration Puget Sound Health Care System, Seattle Division, Seattle, WA.
Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA.
Arch Phys Med Rehabil. 2021 Oct;102(10):1959-1964. doi: 10.1016/j.apmr.2021.05.003. Epub 2021 May 25.
To describe pain intensity and interference in people with progressive multiple sclerosis (MS), compare these with people with relapsing-remitting multiple sclerosis (RRMS), and identify common and unique factors associated with pain intensity in people with progressive MS and RRMS.
Observational, cross-sectional analysis using baseline data from a longitudinal survey on quality of life in participants with MS.
Community.
A total of 573 adults with MS (N=573; progressive MS, n=142; RRMS, n=431).
Not applicable.
Average pain intensity was measured by an 11-point numeric rating scale, and pain interference was measured by the Patient-Reported Outcomes Measurement Information System Pain Interference Short Form.
Participants with progressive MS reported moderate average pain intensity (3.22±2.50) and elevated pain interference (T score of 55.55±9.13). They did not differ significantly from those with RRMS in average pain intensity or pain interference. Common factors associated with higher average pain intensity were more severe disability, lower education level, unemployment, and current smoking. In those with progressive MS, older age was associated with lower average pain intensity.
Pain intensity and interference are similar across MS types. In addition to assessing and treating pain, it is important to screen for modifiable pain-related factors, such as smoking cessation, in this population.
描述进行性多发性硬化症(MS)患者的疼痛强度和疼痛干扰情况,与复发缓解型多发性硬化症(RRMS)患者进行比较,并确定进行性MS和RRMS患者中与疼痛强度相关的共同因素和独特因素。
采用MS患者生活质量纵向调查的基线数据进行观察性横断面分析。
社区。
共有573名成年MS患者(N = 573;进行性MS,n = 142;RRMS,n = 431)。
不适用。
平均疼痛强度采用11点数字评定量表进行测量,疼痛干扰采用患者报告结局测量信息系统疼痛干扰简表进行测量。
进行性MS患者报告的平均疼痛强度为中度(3.22±2.50),疼痛干扰升高(T评分为55.55±9.13)。他们在平均疼痛强度或疼痛干扰方面与RRMS患者无显著差异。与较高平均疼痛强度相关的共同因素包括更严重的残疾、较低的教育水平、失业和当前吸烟。在进行性MS患者中,年龄较大与较低的平均疼痛强度相关。
不同类型的MS患者在疼痛强度和疼痛干扰方面相似。除了评估和治疗疼痛外,在该人群中筛查可改变的疼痛相关因素,如戒烟,也很重要。